JENNA HUGHES: Open Payments
NPI 1831803071 · SAINT JOSEPH, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$689 in 32 payments from 8 companies in 2025. Trend: 2023 $730 · 2024 $895 · 2025 $689
Food & beverage: $689
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 13 | $281 |
| Janssen Pharmaceuticals, Inc | 3 | $157 |
| ABBVIE INC. | 10 | $139 |
| Neurocrine BioSciences, Inc. | 2 | $39 |
| Biogen, Inc. | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
| Alkermes, Inc. | 1 | $15 |
Products named: ABILIFY MAINTENA, INVEGA SUSTENNA, VRAYLAR, REXULTI, ABILIFY ASIMTUFII, INGREZZA, ZURZUVAE, UZEDY.
Industry payments across MO — which companies pay providers there.
